HIMSS and Health 2.0 European Conference

Thank you for attending the 2019 event.
We look forward to seeing you again 26-28 May 2020!

Helsinki, Finland
June 11-13, 2019

MEET OUR KEYNOTE SPEAKERS

The top digital health experts, leaders and speakers will come together in Helsinki. The Finnish Ministry of Health will host the VIP keynote, sharing their impressive story and lessons on how to become one of the strongest health tech economies in the world.


 

Dr Päivi Sillanaukee

Päivi Sillanaukee, MD, PhD, eMBA
Permanent Secretary
Ministry of Social Affairs and Health, Finland

Dr Päivi Sillanaukee was appointed as the Permanent Secretary at the Ministry of Social Affairs and Health in 2012. Ministry’s responsibilities include promotion of health and welfare, social and health services, social insurance, occupational health and safety and gender equality. Between 2008 and 2012, Dr Sillanaukee was the Director General of the Department for Social and Health Services at the Ministry. Prior to that, Dr Sillanaukee was the Deputy Mayor and the Director of Social and Health Services in the City of Tampere. Between 1990 and 2004, Dr Sillanaukee has held various clinical and managerial positions on the Pirkanmaa Hospital District. She was a member of the Tampere city Council in 2001 - 2004.

Dr Sillanaukee, MD, PhD, is a specialist in public health and management from the University of Helsinki. Her academic work ranges from health administration to integrated treatment chains and cost of care. She has an Executive MBA from the University of Tampere. Dr Sillanaukee has participated in the work of several EU, international and global bodies and supervises now also the international activities of the Ministry of Social Affairs and Health.

From May 2018, Dr Sillanaukee has represented Finland as the member of the WHO Executive Board. She currently serves as the co-chair the JEE Alliance which serves as a platform for facilitating multisectoral collaboration on health security capacity building, and as a member of the Steering Group of the Global Health Security Agenda (GHSA).

 

Ministry of Social Affairs and Health, Finland


 

Hal F. Wolf III

Hal F. Wolf III
President & CEO
HIMSS
USA

Harold (Hal) Wolf III is the President and CEO of the Healthcare Information and Management Systems Society (HIMSS). HIMSS consists of HIMSS North America, HIMSS International, cause-based, global membership societies; HIMSS Analytics, the market research and data services group; HIMSS Media, the diversified media and publishing division; PCHAlliance, the Personal Connected Health Alliance; and Health 2.0 the Digital Health Conference—all focused on better health through information and technology. 

With nearly 35 years of experience, Wolf is respected internationally as a healthcare and informatics executive with areas of expertise in mhealth, product development, integrated care models, marketing, distribution, information technology and innovation implementation. He has helped health systems and providers across the world with end-to-end operations, commissioning, data and architectural design.

Before joining HIMSS, Wolf served at The Chartis Group as Director; Practice Leader of Information and Digital Health Strategy. As the key architect in the development of content, research and user interface for video on demand and broadband, Mr. Wolf is a pioneer in consumer engagement. He has contributed his unique approach and insights to the birth of the digital health era, combining the traditional enterprise strategy with an end-to-end organizational view while keeping the patient as the central focus.


 

...

Indu Subaiya
Executive Vice President, Health 2.0
USA

Indu Subaiya is a visionary healthcare leader whose work builds community, creates dialogue and inspires us to radically rethink how our health shapes our lives. Indu co-founded and served as CEO of Health 2.0, the leading conference and media platform that promotes and catalyzes new technologies in healthcare. Health 2.0 was recently acquired by HIMSS and Indu continues to head the organization as Executive Vice President as it scouts new technologies, advances edge and builds initiatives to drive sustainable change in today’s healthcare landscape. Indu is a female immigrant from India and is a passionate advocate for an end to healthcare disparities and increased diversity across the leadership ranks of the industry.


 

Koen Kas

Prof. Dr. Koen Kas

Koen Kas is a health care futurist, entrepreneur, professor of molecular oncology, author, and international keynote speaker.

Koen is driven by the aim to make healthcare delightful, personalized & preventive. He published his vision in two books. 'Sick no more' and 'Your guide to Delight', a roadmap towards Creating health, dealing with change, and introducing our personal Digital Twin.

He is founding CEO of HealthSkouts & Partner at HealthStartup.eu, a social network of novel health startups. With Healthskouts, he helps corporates to unlock unknown unknowns, via an expert-curated, self-learning newsletter with innovation & business development suggestions & insights. He is an expert combining Real World data with design & business model innovations into novel experiences redefining Health.

This way, he develops projects for global companies (Merck, UCB, Pfizer, Nutricia /Danone, Mitsubishi, McKesson, ABInbev) always dealing with personalized, predictive or preventive health and wellness.

Koen is guest professor Oncology at Ghent University, Belgium, and chairs the scientific committee of the European Cancer Prevention Organisation. He is an ambassador for Health House (a healthcare technology experience zone). He serves on the Advisory Board of 7 pioneering healthcare companies and a digital health investor. He is juror of the Prix Galien. He is Editor of the mHealth Journal and the European Journal of Cancer Prevention.

Koen was CSO Oncology at Thrombogenics where he spun out Oncurious, testing a novel drug for pediatric brain cancer. Before he was founder & CSO of Pronota, building a protein biomarker discovery platform and pipeline of 4 diagnostic programs. He was prior to that Director Drug discovery @Galapagos. Previously he set up & directed the Cancer drug discovery program @Tibotec (now J&J). He started his career elucidating the molecular basis of 2 types of cancers.


 

Michael Seres

Michael Seres
Founder & CEO
11Health,
UK

Michael Seres was diagnosed aged 12 with the incurable bowel condition Crohn's disease. In late 2011 he became the 11th person to undergo a small bowel transplant in the UK at the Churchill Hospital in Oxford. He started blogging about his journey through bowel transplantation. His blog has over 95,000 followers, and he uses social media to develop global on line peer to peer communities covering more than 20,000 patients. He devises social media strategies around patient engagement. Michael mentors patients and their families and is a published author and professional speaker. He is the patient lead for #NHSSM, a facilitator for the Centre for Patient Leadership, and digital strategy adviser to the Patients' Association and Oxford Transplant Foundation. Seres is a patient leader involved in creating and implementing patient engagement strategies via digital technologies. He is also the inventor of the Ostomy sensor known as Ostom-i™ Alert Sensor and is founder of 11Health.


 

Aron Anderson

Aron Anderson
Adventurer, entrepreneur and philanthropist
Sweden

Aron Anderson is a Swedish adventurer, philanthropist and motivational speaker. Among his many accomplishments he has climbed Mt Kilimanjaro, biked 1200k from Sweden to Paris, skied to the South Pole and swam from Sweden to Finland. All this since being wheelchair bound at the age of 10. Today Aron is a well known TV-personality, social media influencer and mental coach. He has also managed to raise more then 2 million $ for kids with cancer.


 

Michael Seres

Mark Daly, PhD
Director of the Institute for Molecular Medicine Finland (FIMM) at HiLIFE
University of Helsinki

Mark Daly, PhD, is Director of the Institute for Molecular Medicine Finland (FIMM) at HiLIFE, University of Helsinki. He retains also active affiliations at the Harvard Medical School, Massachusetts General Hospital and the Broad Institute. Daly focuses on development and application of statistical methods in human disease genetics and has made major contributions to gene discovery in inflammatory bowel disease, autism and schizophrenia. At FIMM he explores research and translational uses of Finnish biobank, registry and genome data.


 

Stefanie Veraghtert

Stefanie Veraghtert
Founder, The Big C, Belgium

Stefanie is a social entrepreneur that has a bachelor's degree in Social Work and a master's degree in European Comparative Social Studies. Diagnosed with a stadium 4 Cervical Cancer at the age of 26 she was a young adolescent (AYA) cancer patient. After her treatment and healing she decided to make a big career shift and inspire others with her story. She worked with the Flemish Cancer League and is running her own social enterprise 'The Big C. (Coffee for Cancer) ' that is all about health awareness and empowerment. As a motivational speaker, storyteller and incubator for innovative projects in the healthcare she is promoting cancer awareness.

Stay Informed

Sign up for the latest information on HIMSS Europe events.

 

Sign up now